Charles Cherington - Net Worth and Insider Trading
Charles Cherington Net Worth
The estimated net worth of Charles Cherington is at least $246,280 dollars as of 2024-11-29. Charles Cherington is the Director, 10% Owner of Eterna Therapeutics Inc and owns about 556,465 shares of Eterna Therapeutics Inc (ERNA) stock worth over $244,845. Charles Cherington is also the 10% Owner of Comera Life Sciences Holdings Inc and owns about 7,177,739 shares of Comera Life Sciences Holdings Inc (CMRA) stock worth over $1,436. Details can be seen in Charles Cherington's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Cherington has not made any transactions after 2023-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles Cherington
Charles Cherington Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Cherington owns 3 companies in total, including Eterna Therapeutics Inc (ERNA) , Beard Energy Transition Acquisition Corp (BRD) , and Comera Life Sciences Holdings Inc (CMRA) .
Click here to see the complete history of Charles Cherington’s form 4 insider trades.
Insider Ownership Summary of Charles Cherington
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ERNA | Eterna Therapeutics Inc | 2023-07-13 | 10 percent owner |
| BRD | Beard Energy Transition Acquisition Corp | 2021-11-23 | director |
| CMRA | Comera Life Sciences Holdings Inc | 2023-09-11 | 10 percent owner |
Charles Cherington Latest Holdings Summary
Charles Cherington currently owns a total of 2 stocks. Among these stocks, Charles Cherington owns 556,465 shares of Eterna Therapeutics Inc (ERNA) as of December 2, 2022, with a value of $244,845 and a weighting of 99.42%. Charles Cherington also owns 7,177,739 shares of Comera Life Sciences Holdings Inc (CMRA) as of September 11, 2023, with a value of $1,436 and a weighting of 0.58%.
Latest Holdings of Charles Cherington
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ERNA | Eterna Therapeutics Inc | 2022-12-02 | 556,465 | 0.44 | 244,845 |
| CMRA | Comera Life Sciences Holdings Inc | 2023-09-11 | 7,177,739 | 0.00 | 1,436 |
Holding Weightings of Charles Cherington
Charles Cherington Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Cherington has made a total of 1 transactions in Eterna Therapeutics Inc (ERNA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eterna Therapeutics Inc is the acquisition of 261,756 shares on December 2, 2022, which cost Charles Cherington around $858,560.
According to the SEC Form 4 filings, Charles Cherington has made a total of 8 transactions in Comera Life Sciences Holdings Inc (CMRA) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Comera Life Sciences Holdings Inc is the acquisition of 2,053,789 shares on September 11, 2023, which cost Charles Cherington around $1 Million.
Insider Trading History of Charles Cherington
- 1
Charles Cherington Trading Performance
GuruFocus tracks the stock performance after each of Charles Cherington's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Cherington is -24.17%. GuruFocus also compares Charles Cherington's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Cherington within 3 months outperforms 1 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles Cherington's insider trading performs compared to the benchmark.
Performance of Charles Cherington
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.1 | | | | | |
| Relative Return to S&P 500(%) | -17.47 | | | | | |
Charles Cherington Ownership Network
Charles Cherington Owned Company Details
What does Eterna Therapeutics Inc do?
Who are the key executives at Eterna Therapeutics Inc?
Charles Cherington is the 10 percent owner of Eterna Therapeutics Inc. Other key executives at Eterna Therapeutics Inc include 10 percent owner Freebird Investments Llc , 10 percent owner Freebird Partners Lp , and 10 percent owner Curtis W Huft .
Eterna Therapeutics Inc (ERNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eterna Therapeutics Inc (ERNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eterna Therapeutics Inc (ERNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eterna Therapeutics Inc (ERNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eterna Therapeutics Inc Insider Transactions
Charles Cherington Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Cherington. You might contact Charles Cherington via mailing address: One Bow Street, Cambridge Ma 02138.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
